Special Issue "Tobacco Harm Reduction"
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Behavior, Chronic Disease and Health Promotion".
Deadline for manuscript submissions: closed (31 December 2018).
Interests: tobacco control; tobacco harm reduction; alternative nicotine products; priority populations and health disparities; environmental health
Special Issues and Collections in MDPI journals
Interests: tobacco cessation; tobacco harm reduction; priority populations and health disparities; health communication; online social media; dental public health
Interests: tobacco control; health communication; smoking cessation; addiction beliefs; lay understandings of health and illness
Tobacco Harm Reduction has been a controversial area in public health, largely due to the promotion by the tobacco industry of cigarette modifications that gave the appearance of reduced harm, without reducing health risk. This may have increased overall harm by discouraging smokers from quitting. However, there is now good evidence that switching from cigarettes to some alternate nicotine and tobacco products can reduce exposure to harmful constituents and reduce health risk. The Swedish experience with snus, a form of oral snuff manufactured to limit the formation of carcinogenic nitrosamines, is an example of an alternate tobacco product with long-term epidemiological evidence to support its much lower risk profile. Newer products, such as e-cigarettes and other vaping devices and heated tobacco products are generating substantial interest. While this is a rapidly advancing research field, the recent National Academies of Science, Engineering and Medicine Report on the Public Health Consequences of E-cigarettes has identified a number of priority areas for research to help fill some of the gaps in evidence on these alternate nicotine and tobacco products. This Special Issue of IJERPH on Tobacco Harm Reduction welcomes submissions on these priority research areas and other research that advances our understanding of the potential place of tobacco harm reduction within a comprehensive strategy to reduce the burden of smoking related disease and assists policy makers to determine what level of regulation is most appropriate.Assoc. Prof. Coral Gartner
Dr. Ratika Sharma-Kumar
Dr. Kylie Morphett
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tobacco harm reduction
- vaporized nicotine products
- smokeless tobacco
- heated tobacco
- secondhand exposure
- harmful and potentially harmful constituents
- relative risk
- dual use